NovAccess Global Inc.: NovAccess Global Launches Precision M

CLEVLAND, OH / ACCESSWIRE / June 1, 2023 / NovAccess Global Inc. (OTCQB:XSNX), a biomedical company developing novel immunotherapies for brain tumor patients, today announced the formation of its Precision

Related Keywords

Dwaink Irvin , , Our Company , Securities Exchange , Predictive Technology , Novaccess Global Inc , Novaccess Global Inc View , Darrow Associates , Securities Exchange Commission , Precision Medicine Division , Novaccess Global , Big Data , Chief Executive Officer , Access Global , Securities Act , Securities Exchange Act , Private Securities Litigation Reform Act , Relations Contact , Novaccess , Lobal , Aunches , Precision , Medicine , Division , Sing , Data , Predictive , Technologies , Ccelerate , Personalized , Healthcare , Therapies ,